November 22nd 2024
At least 1 accurate UTI symptom was found on most of the 331 websites reviewed, but nearly all (80%) included at least 1 inaccurate or misleading one.
November 20th 2024
The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.
Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.
November 13th 2024
More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.
November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
“Nocebo” Effect Accounted for Nearly Two-thirds of COVID-19 Vaccine Adverse Events in New Analysis
Findings highlight the importance of educating the public about the potential for nocebo responses to help reduce worries about COVID-19 vaccination.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 18, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
At-home STD Tests in California Must be Covered by Insurance, says New Law
California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 14, 2022
Seen in the ED: Positive Blood Culture
A man in his mid-60s presents after 1 month of intermittent fevers; recent blood cultures were positive for oral flora. Follow the ED course--can you make the diagnosis?
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 13, 2022
7 COVID-19 Home Test Kits Ranked by Usability
Seven at-home COVID-19 rapid tests, all available online or at retail, are ranked for dexterity required, instruction legibility, and other features you may need to parse for your patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 11, 2022
Non-COVID-19 Vaccines Could Help Reduce the Burden of Pandemic, Suggests New Research
New research suggests heterologous vaccine interventions with low efficacy can significantly reduce COVID-19 cases, hospitalizations, and deaths.
US Flu Activity for the Week Ended 1/1/2022
Click through top flu indicators tracked by the Centers for Disease Control and Prevention weekly US influenza surveillance report.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 7, 2022
Atopic Disease, Particularly Asthma, Linked to Decreased Risk of COVID-19 Infection in UK Adults
Adults with atopic disease and asthma had a 38% decreased risk of COVID-19 infection, according to a new UK study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 5, 2022
AAP Recommends Routine HIV Screening for all Adolescents Starting at Age 15
The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.
New Study Suggests Obesity is Modifiable Risk Factor for Severe COVID-19 Infection
Among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of severe COVID-19, suggests new research.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
J&J Booster Found 85% Effective Against Severe Disease During Peak Omicron Case Load
The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022
FDA Authorizes Use of Pfizer COVID-19 Vaccine Booster Dose in Children Aged 12 to 15 Years
Pending endorsement from the CDC, adolescents can now get a booster dose of the Pfizer-BioNTech vaccine, as authorized by an amendment to the original FDA EUA for the vaccine.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 20, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 14, 2021
Persistent Dyspnea in Patients with Long COVID-19 May Indicate Heart Issues
New research presented at EuroEcho 2021 may help explain why some patients with long COVID-19 experience persistent dyspnea even 1 year after recovery.
Flu Responds to COVID-19 Allegations: Press Conference Transcript
Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 9, 2021
Pfizer: Protection Against Omicron Variant ‘Improved’ After 3 Doses of COVID-19 Vaccine
New preliminary laboratory data showed 3 doses of the Pfizer-BioNTech COVID-19 vaccine neutralized the Omicron variant while 2 doses reduced neutralization titers.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 8, 2021